Amgen reports third quarter 2016 financial results
Amgen reported 2016 third quarter revenues increased 2 percent versus the third quarter of 2015 to $5.8 billion. Total revenues guidance increased to $22.6-$22.8 billion; EPS guidance increased to $9.94-$10.11 on a GAAP basis and $11.40-$11.55 on a non-GAAP basis. October 27, 2016